Vanguard Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8M | Buy |
|
|||||
|
2025
Q1 | $44.5M | Buy |
|
|||||
|
2024
Q4 | $26.8M | Buy |
|
|||||
|
2024
Q3 | $22.1M | Buy |
|
|||||
|
2024
Q2 | $17.2M | Buy |
|
|||||
|
2024
Q1 | $16.8M | Buy |
|
|||||
|
2023
Q4 | $16.7M | Buy |
|
|||||
|
2023
Q3 | $13.1M | Buy |
|
|||||
|
2023
Q2 | $18.2M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Buy |
|
|||||
|
2022
Q4 | $8.78M | Buy |
|
|||||
|
2022
Q3 | $10.2M | Buy |
|
|||||
|
2022
Q2 | $9.69M | Buy |
|
|||||
|
2022
Q1 | $13.3M | Buy |
|
|||||
|
2021
Q4 | $15M | Buy |
|
|||||
|
2021
Q3 | $7.29M | Sell |
|
|||||
|
2021
Q2 | $12.1M | Buy |
|
|||||
|
2021
Q1 | $12.4M | Buy |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|
|||||
|
2020
Q3 | $13.2M | Buy |
|
|||||
|
2020
Q2 | $5.76M | Buy |
|
|||||
|
2020
Q1 | $3.3M | Buy |
|
|||||
|
2019
Q4 | $9.29M | Buy |
|
|||||
|
2019
Q3 | $12.7M | Buy |
|
|||||
|
2019
Q2 | $13.9M | Buy |
|
|||||
|
2019
Q1 | $11.4M | Buy |
|
|||||
|
2018
Q4 | $5.58M | Buy |
|
|||||
|
2018
Q3 | $4.48M | Buy |
|
|||||
|
2018
Q2 | $474K | Buy |
|